About us
Concord International Hospital is a private hospital that provides personalised and dedicated healthcare services to local and international patients.
OUR STORY
1993
PARTNER
CONCORD MEDICAL
Installed our First Head Gamma System and First MRI Scanner in Guangzhou
2000
Installed our First Body Gamma System in Guangzhou
2006
Listed on London Stock Exchange’s AIM Market
2009
Listed on New York Stock Exchange in December 2009
2013
Announced successful closing of the acquisition of ownership interest in MD Anderson Cancer Center
2014
EXCLUSIVE CONSULTANT
MD ANDERSON CANCER CENTER
Signed consulting agreement with
MD Anderson Cancer Center
2015
Acquired Fortis Surgical Hospital and renamed the hospital to Concord Cancer Hospital
2017
CONCORD INTERNATIONAL HOSPITAL
Concord Cancer Hospital was renamed to
Concord International Hospital
CONCORD INTERNATIONAL HOSPITAL
Concord International Hospital is a member of Concord Medical Services Holdings Limited (NYSE: CCM), a speciality hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centres in China.
Company Profile
At Concord International Hospital, we provide an entirely personalised healthcare experience with efficient service and professional medical care. Our definition of private healthcare is to give our patients comfort and quality medical and nursing care in a cosy and elegant setting.
Our strong affiliation with The University of Texas MD Anderson Cancer Center in the United States as well as the medical technologies at CIH enable us to provide compassionate and professional nursing care.
Our medical services include comprehensive cancer-related treatments, women’s health services, minor and major surgeries, robotic and minimally-invasive-surgeries. We also offer a wide range of health screening and wellness packages.
SIGNATURE SERVICES
Clinical Equipment
MD Anderson Cancer Center
We ensure treatment success for our patients and their families; bringing our cancer care closer to home through leveraging our strategic and exclusive collaboration with The University of Texas MD Anderson Cancer Centre in the United States which is recognised as the global leading authority on cancer healthcare.
Through this close collaboration, we hope to develop a multidisciplinary cancer care; sub-specialised and research-driven oncology programme so as to optimise patient experience and improve cancer care.
CONCORD MEDICAL
Patient First is our philosophy. Taking International standards of diagnosis and caring like families as its tenet, MD Joint has developed the world’s leading medical treatment programmes and treatment procedures to provide different types of solid tumour diagnosis and treatment services for both male and female patients, including breast, lung, prostate, liver, ovary, uterus, cervix, oesophagus, stomach, pancreas, large intestine.
